Filing Summary: Fresenius Medical Care AG (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed on February 24, 2026, by Fresenius Medical Care AG, a foreign private issuer. The filing serves to announce the Company's fourth quarter and full-year financial results for the period ending December 31, 2025. The report includes a press release (Exhibit 99.1) and a complete overview of financial figures (Exhibit 99.2).
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached exhibits (Exhibit 99.1 and Exhibit 99.2) referenced in the document.
The Company reports using International Financial Reporting Standards (IFRS) and supplements these with the following non-GAAP measures:
- EBITDA: Operating income excluding interest, taxes, depreciation, and amortization.
- Free Cash Flow.
- Net Leverage Ratio: Ratio of net debt to adjusted EBITDA.
- Constant Currency Results: Adjusted for special items identified in the press release.
Material Changes and Comparisons
The filing text does not disclose specific material changes, growth rates, or comparisons to the prior comparable period. The document states that the attached press release and financial statements contain the necessary data to understand performance trends and special items.
Guidance, Outlook, and Risks
Specific guidance, outlook, management commentary, or risk factors are not detailed in the cover letter of this Form 6-K. The filing notes that the attached press release provides non-GAAP measures to enhance the understanding of current performance and future prospects. Reconciliations between non-GAAP and IFRS measures are included in the attached financial statements.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2025 revenue, EBITDA, and net income figures.
- Examine Exhibit 99.2 for the complete financial overview and reconciliation of non-GAAP measures to IFRS.
- Verify the Net Leverage Ratio and Free Cash Flow as reported in the exhibits.
- Check for any special items or adjustments made to the financial results as described in the press release.
- Confirm the constant currency impact on reported growth metrics.